China Pharma Holdings (CPHI) has released an update to notify the public and investors about an entry into a material definitive agreement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
China Pharma Holdings’ subsidiary Helpson has acquired an invention patent for a psoriasis treatment from inventor Lihua Li for $1.50 million in company stock. The deal includes additional technical services from the Transferor and a decade-long profit-sharing arrangement where Helpson will pay 10% of annual net profits from the product to the Transferor, conditional upon the product’s profitability.
For further insights into CPHI stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.